Page 135 - Bank-Muamalat_Annual-Report-2023
P. 135

ANNUAL REPORT 2023
                                                                                                         GOVERNANCE














            ROSHIDAH
            ABDULLAH

            Independent
            Non-Executive Director


             Nationality      Malaysian
             Age and Gender   57 | Female
             Date of Appointment  1 September 2021
             Meeting Attendance  9/11













            Roshidah  Abdullah  was  appointed  as  an  Independent  Non-Executive  Director  of  Bank  Muamalat  Malaysia  Berhad  on
            1  September  2021.  She  is  the  Chairman  of  the  Board  Audit  Committee  and  a  member  of  the  Board  Nomination  &
            Remuneration and Board Technology Committees.

            Roshidah  has  more  than  25  years  experience  in  financial  management,  corporate  strategy  development,  governance  and
            risk  management  in  various  organisations  across  diverse  industries  –  upstream  oil  and  gas;  pharmaceutical  manufacturing
            and  distribution;  construction  and  engineering  –  with  operations  in  Malaysia  and  abroad  (particularly  Kazakhstan,  Indonesia
            and the Middle East). Having worked for almost 20 years in public listed companies and large conglomerates in the capacity
            of  Chief  Financial  Officer  and  equivalent  positions,  she  has  had  much  exposure  to  the  requirements  and  set  up  of  code  of
            corporate governance and enterprise-wide risk management framework in her previous organisations.
            Roshidah  started  her  career  as  an  auditor  with  Deloitte  and  Touche  (Kassim  Chan  &  Co)  in  1989.  She  left  the  firm  in
            December 1992 to join Time Engineering Berhad as a Group Accountant.
            In  January  1995,  Roshidah  moved  to  Remedi  Pharmaceuticals  (M)  Sdn  Bhd  (Remedi)  to  head  the  Finance  Department.
            Remedi  was  at  that  point  just  secured  a  15-year  concession  contract  to  manage  the  drug  procurement  for  the  Ministry  of
            Health  Malaysia.  She  was  also  directly  involved  in  the  merger  and  acquisition  of  Remedi,  Raza  Manufacturing  Berhad
            and  Strand  Pharmaceuticals  Sdn  Bhd  by  Pharmaniaga  Berhad  (Pharmaniaga)  in  1998,  and  the  subsequent  public  listing  of
            Pharmaniaga  on  Bursa  Securities  in  1999.  In  January  2000,  Roshidah  was  promoted  as  the  General  Manager  Finance  and
            later  in  April  2003,  as  the  Chief  Financial  Officer  for  Pharmaniaga.  She  was  also  Pharmaniaga’s  Chief  Operating  Officer
            from 2006 to March 2008.
            Roshidah then spent the next two years until early 2010 as Finance Director at UEM Group Berhad and UEM Builders Berhad
            before  she  returned  to  Pharmaniaga  to  assist  the  Company  to,  amongst  others,  finalise  its  negotiation  for  renewal  of  the
            concession agreement and prepare for the change in controlling shareholders.

            After  leaving  Pharmaniaga  in  March  2011,  Roshidah  had  a  short  stint  as  a  business  consultant.  Then  from  April  2013  to
            October 2016, she was the Chief Financial Officer with Sumatec Resources Berhad.
            She is an Independent Non-Executive Director of Pos Malaysia Berhad.
            Roshidah  obtained  a  Bachelors  of  Arts  degree  in  Accountancy  from  South  Australian  Institute  of  Technology,  Australia
            (now  known  as  University  of  South  Australia)  in  1988.  She  is  also  a  chartered  member  of  Malaysian  Institute  of  Accountants
            and a certified member of Australian CPA since 1992.
                                                                                                                  133
   130   131   132   133   134   135   136   137   138   139   140